To explore the biological function of DDX39B in CRC, we first examined the transfection efficiency in CRC cells with DDX39B overexpression and knockdown using western blotting, qRT-PCR (Fig. 2A, B), and immunofluorescence (IF) (Fig. S1C). The gene discussed is DDX39B; the disease is colorectal carcinoma.